An increased level of amyloid in the blood after an ischemic episode [72,73] can indirectly affect changes in tau protein in the blood, representing an automated link between the accumulated amyloid and tau protein pathology after ischemic blood–brain barrier failure [74]. The gene discussed is MAPT; the disease is amyloidosis.